» Articles » PMID: 36226971

Mediterranean Diet is Linked to Less Objective Disability in Multiple Sclerosis

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2022 Oct 13
PMID 36226971
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The multiple sclerosis (MS) community is highly interested in diet as a potential protective factor against disability, but empirical evidence remains limited.

Objective: Evaluate associations between patient-reported Mediterranean diet alignment and objective disability in a real-world MS cohort.

Methods: Data were analyzed from persons with MS, aged 18-65, who completed the Mediterranean Diet Adherence Screener (MEDAS), MS Functional Composite (MSFC; primary disability metric), and patient-reported outcomes (PROs; disability, gait disturbance, fatigue, anxiety, and depression) as part of our Comprehensive Annual Assessment Program. Multiple regression predicted MSFC (and PROs) with MEDAS after adjusting for demographic (age, sex, race, ethnicity, and socioeconomic status) and health-related (body mass index (BMI), exercise, sleep disturbance, hypertension, diabetes, hyperlipidemia, and smoking) covariates.

Results: Higher MEDAS independently predicted better outcomes across MSFC (-score,  = 0.10 (95% confidence interval (CI): 0.06, 0.13), β = 0.18,  < 0.001), MSFC components, and PROs in 563 consecutive patients. Each MEDAS point was associated with 15.0% lower risk for MSFC impairment (⩽ 5th percentile on ⩾ 2 tasks; odds ratio (OR) = 0.850; 95% CI: 0.779, 0.928). Higher MEDAS attenuated effects of progressive disease and longer disease duration on disability.

Conclusion: With robust control for potential confounds, higher Mediterranean diet alignment predicted lower objective and patient-reported disability. Findings lay the necessary groundwork for longitudinal and interventional studies to guide clinical recommendations in MS.

Citing Articles

White Matter Lesion Volumes on 3-T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 Years.

Jaftha M, Robertson F, van Rensburg S, Kidd M, van Toorn R, Kemp M Mult Scler Int. 2024; 2024:8818934.

PMID: 39524062 PMC: 11548950. DOI: 10.1155/2024/8818934.


Neuroprotective effect of neuron-specific deletion of the C16 ceramide synthetic enzymes in an animal model of multiple sclerosis.

Amatruda M, Marechal D, Gacias M, Wentling M, Turpin-Nolan S, Morstein J Glia. 2024; 73(2):271-290.

PMID: 39489703 PMC: 11662985. DOI: 10.1002/glia.24631.


Diet-Induced Changes in Functional Disability among People with Multiple Sclerosis: A Secondary Pooled Analysis of Two Randomized Controlled Pilot Trials.

Groux A, Walker E, Shemirani F, Lee J, Irish A, Rubenstein L Sclerosis. 2024; 2(3):156-165.

PMID: 39296470 PMC: 11410177. DOI: 10.3390/sclerosis2030011.


Sociodemographic, Health, and Lifestyle-Related Characteristics Associated With the Commencement and Completion of a Web-Based Lifestyle Educational Program for People With Multiple Sclerosis: Randomized Controlled Trial.

Reece J, Yu M, Bevens W, Simpson-Yap S, Davenport R, Jelinek G J Med Internet Res. 2024; 26:e58253.

PMID: 39197163 PMC: 11391162. DOI: 10.2196/58253.


Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis.

Ghezzi L, Tosti V, Shi L, Cantoni C, Mikesell R, Lancia S J Neurol Neurosurg Psychiatry. 2024; 96(2):158-169.

PMID: 39137977 PMC: 11877063. DOI: 10.1136/jnnp-2024-333465.


References
1.
Evans E, Levasseur V, Cross A, Piccio L . An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Mult Scler Relat Disord. 2019; 36:101393. DOI: 10.1016/j.msard.2019.101393. View

2.
Godin G, Shephard R . A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985; 10(3):141-6. View

3.
Sand I . The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence. Curr Nutr Rep. 2018; 7(3):150-160. PMC: 6132382. DOI: 10.1007/s13668-018-0236-z. View

4.
Brenton J, Goldman M . A study of dietary modification: Perceptions and attitudes of patients with multiple sclerosis. Mult Scler Relat Disord. 2016; 8:54-7. DOI: 10.1016/j.msard.2016.04.009. View

5.
Goldman M, Ward M, Motl R, Jones D, Pula J, Cadavid D . Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale. Mult Scler. 2016; 23(10):1405-1414. PMC: 5411321. DOI: 10.1177/1352458516680749. View